You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 89 No. 3, March 1955 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Piperazine in the Treatment of Enterobiasis

CAPT. MORTON H. RACHELSON, (MC), U. S. A. F.; LIEUT. WILLARD R. FERGUSON, (MC), U.S.A. F.

AMA Am J Dis Child. 1955;89(3):346-349.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Enterobiasis is the most common helminth infestation in the United States. The pinworm has proved to be a difficult parasite to eradicate for the human race. Although reports of therapeutic agents have filled the medical literature throughout the years, not one drug has been universally accepted. Cram1 gave the following criteria for a satisfactory agent:

  1. The drug must be highly effective in removing pinworms.
  2. The drug must be relatively nontoxic, so that it can be given in repeated treatments over a period during which viable pinworm ova may be present in the patient's surroundings, the repeated administration of the drug also assuring its entrance into the cecum and appendix, common sites of pinworm infection.
  3. The treatment must be of such reasonable cost that its use in large families will not be prohibitive.
  4. The treatment must be so easily administered that it can be used with
. . . [Full Text PDF of this Article]


Author Affiliations



From the Department of Pediatrics, 1600th U.S.A.F. Hospital, Westover Air Force Base, Mass.


Footnotes



The piperazine used in this study was supplied by Burroughs Wellcome & Company as Syrup of Antepar.

Present address: Children's Medical Center, 300 Longwood Ave., Boston 15 (Dr. Rachelson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.